XPH vs. ARKG ETF Comparison

Comparison of SPDR S&P Pharmaceuticals ETF (XPH) to ARK Genomic Revolution Multi-Sector ETF (ARKG)

XPH

SPDR S&P Pharmaceuticals ETF

XPH Description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Grade (RS Rating)

Last Trade

$46.64

Average Daily Volume

60,002

Number of Holdings ^*

* may have additional holdings in another (foreign) market

ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description

Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$23.90

Average Daily Volume

2,215,896

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	XPH	ARKG
30 Days	-0.77%	-3.53%
60 Days	3.73%	-11.54%
90 Days	5.39%	-13.90%
12 Months	28.11%	-15.87%

0 Overlapping Holdings

	Symbol	Grade	Weight in XPH	Weight in ARKG	Overlap

XPH Overweight 44 Positions Relative to ARKG

Symbol	Grade	Weight
CORT	B	4.96%
LBPH	A	4.12%
BMY	B	4.11%
ITCI	C	4.01%
JAZZ	B	3.94%
VTRS	A	3.73%
AXSM	B	3.59%
EWTX	C	3.42%
CTLT	C	3.41%
ELAN	D	3.35%
PRGO	C	3.35%
RPRX	D	3.18%
JNJ	C	3.17%
ZTS	D	3.15%
PFE	F	3.07%
LLY	F	2.94%
MRK	D	2.93%
TARS	C	2.81%
OGN	F	2.58%
SAVA	C	2.57%
ARVN	F	2.53%
PBH	A	2.5%
SUPN	C	2.15%
AMPH	F	2.02%
PCRX	C	1.91%
LGND	C	1.77%
ANIP	F	1.54%
COLL	F	1.48%
OCUL	D	1.44%
AMRX	C	1.33%
MNMD	C	1.23%
HRMY	D	1.22%
WVE	C	1.17%
HROW	D	1.17%
INVA	D	0.98%
EYPT	D	0.94%
LQDA	F	0.89%
PLRX	D	0.87%
FULC	F	0.85%
ELVN	D	0.64%
NUVB	C	0.6%
EOLS	D	0.52%
PHAT	F	0.48%
XERS	C	0.46%

XPH Underweight 34 Positions Relative to ARKG

Symbol	Grade	Weight
TWST	F	-8.37%
RXRX	F	-7.42%
CRSP	D	-7.34%
ADPT	C	-5.03%
CDNA	D	-4.77%
VCYT	B	-4.51%
SDGR	C	-4.14%
BEAM	D	-4.01%
NTLA	F	-3.89%
IONS	F	-3.85%
NTRA	A	-3.82%
NRIX	C	-3.78%
TXG	F	-3.56%
GH	B	-3.49%
ARCT	F	-3.19%
PSNL	D	-2.7%
ABSI	F	-2.19%
PACB	F	-2.16%
BFLY	B	-1.71%
VEEV	C	-1.7%
AMGN	F	-1.68%
ACCD	D	-1.47%
VRTX	D	-1.29%
ILMN	C	-1.25%
CERS	D	-1.18%
INCY	C	-1.11%
REGN	F	-0.92%
PRME	F	-0.9%
CMPS	F	-0.75%
MASS	F	-0.69%
QSI	C	-0.68%
EXAS	D	-0.65%
RPTX	F	-0.64%
MRNA	F	-0.01%

XPH: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution

ARKG: Top Represented Industries & Keywords

Industries: Biotechnology Diagnostics & Research Health Information Services Health Information Services Medical Devices Drug Manufacturers - Major Medical Care Facilities